Immatics at the Antibody & Therapeutics Asia Conference (Feb 26-28) in Tokyo, Japan

| News, USA

Immatics will attend the Antibody Engineering & Therapeutics Asia Conference (Feb 26-28) in Tokyo, Japan! Join us and discuss the Immatics' TCR approach for cancer immunotheraphy:

 

Wednesday, February 27

4.30pm - 5pm

Presentation: "Selection and Development of Potent T-cell Receptors for Cancer Immunotherapy"

Presenter: Dominik Maurer (VP Immunology)

 

We’re looking forward to meet you.

Further information on the Antibody Engineering & Therapeutics Asia Conference here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back